| 151 |
21127754 | Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling. | 2008 Nov 1 |
2 |
| 152 |
17388918 | Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. | 2007 Jun |
1 |
| 153 |
16959960 | Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. | 2006 Dec |
1 |
| 154 |
16985072 | Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. | 2006 Sep |
2 |